290 related articles for article (PubMed ID: 20200004)
21. Delivery of megsin siRNA plasmid reveals therapeutic potential against diabetic nephropathy by down-regulating p27(kip1) level.
Liu M; Zhang Y; Chi Y; Zhai S; Wang B; Shi Y; Li Y
J Nephrol; 2012; 25(3):418-25. PubMed ID: 21928229
[TBL] [Abstract][Full Text] [Related]
22. TGF-beta(1) downregulates PTHrP in coronary endothelial cells.
Wenzel S; Schorr K; Degenhardt H; Frischkopf K; Kojda G; Wiesner RJ; Rosenkranz S; Piper HM; Schlüter KD
J Mol Cell Cardiol; 2001 Jun; 33(6):1181-90. PubMed ID: 11444922
[TBL] [Abstract][Full Text] [Related]
23. Oxidized LDL induces proliferation and hypertrophy in human umbilical vein endothelial cells via regulation of p27Kip1 expression: role of RhoA.
Seibold S; Schürle D; Heinloth A; Wolf G; Wagner M; Galle J
J Am Soc Nephrol; 2004 Dec; 15(12):3026-34. PubMed ID: 15579505
[TBL] [Abstract][Full Text] [Related]
24. Novel interactions between TGF-{beta}1 actions and the 12/15-lipoxygenase pathway in mesangial cells.
Kim YS; Xu ZG; Reddy MA; Li SL; Lanting L; Sharma K; Adler SG; Natarajan R
J Am Soc Nephrol; 2005 Feb; 16(2):352-62. PubMed ID: 15615821
[TBL] [Abstract][Full Text] [Related]
25. High glucose induces macrophage inflammatory protein-3 alpha in renal proximal tubule cells via a transforming growth factor-beta 1 dependent mechanism.
Qi W; Chen X; Zhang Y; Holian J; Mreich E; Gilbert RE; Kelly DJ; Pollock CA
Nephrol Dial Transplant; 2007 Nov; 22(11):3147-53. PubMed ID: 17664181
[TBL] [Abstract][Full Text] [Related]
26. Density-dependent shift of transforming growth factor-beta-1 from inhibition to stimulation of vascular smooth muscle cell growth is based on unconventional regulation of proliferation, apoptosis and contact inhibition.
Hneino M; Bouazza L; Bricca G; Li JY; Langlois D
J Vasc Res; 2009; 46(2):85-97. PubMed ID: 18596377
[TBL] [Abstract][Full Text] [Related]
27. Deletion of protein kinase C-beta isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozotocin-induced diabetic mouse model.
Meier M; Park JK; Overheu D; Kirsch T; Lindschau C; Gueler F; Leitges M; Menne J; Haller H
Diabetes; 2007 Feb; 56(2):346-54. PubMed ID: 17259378
[TBL] [Abstract][Full Text] [Related]
28. BMP7 is a podocyte survival factor and rescues podocytes from diabetic injury.
Mitu GM; Wang S; Hirschberg R
Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1641-8. PubMed ID: 17804487
[TBL] [Abstract][Full Text] [Related]
29. Podocyte hypertrophy in diabetic nephropathy.
Kim NH
Nephrology (Carlton); 2005 Oct; 10 Suppl():S14-6. PubMed ID: 16174280
[TBL] [Abstract][Full Text] [Related]
30. Endocervical cancer is associated with an increase in the ligands and receptors for transforming growth factor-beta and a contrasting decrease in p27(Kip1).
Farley J; Gray K; Nycum L; Prentice M; Birrer MJ; Jakowlew SB
Gynecol Oncol; 2000 Aug; 78(2):113-22. PubMed ID: 10926789
[TBL] [Abstract][Full Text] [Related]
31. Parathyroid hormone-related protein interacts with vascular endothelial growth factor to promote fibrogenesis in the obstructed mouse kidney.
Ardura JA; Berruguete R; Rámila D; Alvarez-Arroyo MV; Esbrit P
Am J Physiol Renal Physiol; 2008 Aug; 295(2):F415-25. PubMed ID: 18550647
[TBL] [Abstract][Full Text] [Related]
32. A novel role for the cyclin-dependent kinase inhibitor p27(Kip1) in angiotensin II-stimulated vascular smooth muscle cell hypertrophy.
Braun-Dullaeus RC; Mann MJ; Ziegler A; von der Leyen HE; Dzau VJ
J Clin Invest; 1999 Sep; 104(6):815-23. PubMed ID: 10491417
[TBL] [Abstract][Full Text] [Related]
33. Reactive oxygen species stimulate p44/42 mitogen-activated protein kinase and induce p27(Kip1): role in angiotensin II-mediated hypertrophy of proximal tubular cells.
Hannken T; Schroeder R; Zahner G; Stahl RAK; Wolf G
J Am Soc Nephrol; 2000 Aug; 11(8):1387-1397. PubMed ID: 10906152
[TBL] [Abstract][Full Text] [Related]
34. Role of p27(Kip1) in cAMP- and TGF-beta2-mediated antiproliferation in rabbit corneal endothelial cells.
Kim TY; Kim WI; Smith RE; Kay ED
Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3142-9. PubMed ID: 11726615
[TBL] [Abstract][Full Text] [Related]
35. Ectopic expression of Cdk6 circumvents transforming growth factor-beta mediated growth inhibition.
Zhang F; Taipale M; Heiskanen A; Laiho M
Oncogene; 2001 Sep; 20(41):5888-96. PubMed ID: 11593394
[TBL] [Abstract][Full Text] [Related]
36. IGF-binding protein-3 modulates TGF-beta/BMP-signaling in glomerular podocytes.
Peters I; Tossidou I; Achenbach J; Woroniecki R; Mengel M; Park JK; Paschy M; de Groot K; Haller H; Schiffer M
J Am Soc Nephrol; 2006 Jun; 17(6):1644-56. PubMed ID: 16672319
[TBL] [Abstract][Full Text] [Related]
37. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.
Datta NS; Chen C; Berry JE; McCauley LK
J Bone Miner Res; 2005 Jun; 20(6):1051-64. PubMed ID: 15883646
[TBL] [Abstract][Full Text] [Related]
38. Positive feedback loop between plasminogen activator inhibitor-1 and transforming growth factor-beta1 during renal fibrosis in diabetes.
Seo JY; Park J; Yu MR; Kim YS; Ha H; Lee HB
Am J Nephrol; 2009; 30(6):481-90. PubMed ID: 19786738
[TBL] [Abstract][Full Text] [Related]
39. Stretch reduces nephrin expression via an angiotensin II-AT(1)-dependent mechanism in human podocytes: effect of rosiglitazone.
Miceli I; Burt D; Tarabra E; Camussi G; Perin PC; Gruden G
Am J Physiol Renal Physiol; 2010 Feb; 298(2):F381-90. PubMed ID: 19906946
[TBL] [Abstract][Full Text] [Related]
40. TGF-β1 stimulates human Tenon's capsule fibroblast proliferation by miR-200b and its targeting of p27/kip1 and RND3.
Tong J; Fu Y; Xu X; Fan S; Sun H; Liang Y; Xu K; Yuan Z; Ge Y
Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2747-56. PubMed ID: 24667864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
